Literature DB >> 21262192

Analysis of TPOX short tandem repeat locus with matrix-associated laser desorption/ionization time-of-flight-based restriction fragment mass polymorphism assay.

Yoon Seok Cha1, Suh Hee Choi, Joo-Hyoung Lee, Soo-Kyung Shin, Seung Hwan Lee, Soong Deok Lee, Soo-Ok Kim, Sun Pyo Hong.   

Abstract

Short tandem repeat (STR) loci are routinely analyzed by capillary electrophoresis. However, this method has several disadvantages, including long operational time, low throughput, and inaccuracy. As a result of the introduction of matrix-associated laser desorption/ionization time-of-flight (MALDI-TOF) and electrospray ionization (ESI), mass spectrometry has become an alternative method for genotyping polymorphic STR loci. Here we established a restriction fragment mass polymorphism (RFMP) assay for genotyping STR locus, TPOX, by typeIIS restriction endonuclease cleavage of polymerase chain reaction (PCR) amplicon followed by MALDI-TOF mass spectrometry. The resulting TPOX genotypes from this assay were in good agreement with the results from direct DNA sequencing and GeneScan assays. Our results showed that the RFMP assay is an accurate and high-throughput method for analyzing long DNA fragments such as STR markers. Further research with multiple STR loci may allow this assay to be used for diverse applications such as forensics, paternity tests, and detection of genetic disorders.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21262192     DOI: 10.1016/j.ab.2011.01.023

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  1 in total

1.  Restriction fragment mass polymorphism (RFMP) analysis based on MALDI-TOF mass spectrometry for detecting antiretroviral resistance in HIV-1 infected patients.

Authors:  J-H Lee; A Hachiya; S-K Shin; J Lee; H Gatanaga; S Oka; K A Kirby; Y T Ong; S G Sarafianos; W R Folk; W Yoo; S P Hong; S-O Kim
Journal:  Clin Microbiol Infect       Date:  2013-03-11       Impact factor: 8.067

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.